Niche expertise Wheelhouse Life Science Advisors specializes in Investor Relations and Corporate Communications for life science companies, positioning them as a targeted partner for biotech firms seeking to enhance visibility with investors, media, and employees.

Growth potential With a revenue range of one to ten million and a small team, there is an opportunity to scale services through partnerships with mid-market life science firms looking to professionalize IR and communications as they seek funding rounds, product launches, or market expansion.

Sector credibility In‑house life science experience and prior boardroom exposure suggest credibility in regulatory and investor narratives, which can be leveraged to win mandates from emerging biotech start‑ups and clinical stage companies seeking investor intelligence and storytelling.

Tech readiness Existing technology stack including Microsoft 365, Google Analytics, and standard web/server tools indicates readiness to deploy data-driven PR and investor targeting with analytics, tracking, and optimized digital outreach.

Competitive landscape Operating in a market with large IR and healthcare consultancies; potential for differentiating through specialized life science focus, fast turnaround, and integrated storytelling that aligns investor messaging with company vision during funding, partnerships, and product milestones.